Patent AnalyticsExaminers
Rankings

Company or institution

scPharmaceuticals Inc.

22 applicationsfiled 2015 to 2026

Allowance rate
94%
+18 pts vs the USPTO range 72% to 99%
Rejections before allowance
1.0
−0.6 vs the USPTO
Months to first action
7.7 mo
−10.9 vs the USPTO
Needed an RCE
17%
−10 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations11 apps
A61P Therapeutic activity of compounds11 apps

Art units

161510 apps
16134 apps
OPAP3 apps
16262 apps
16751 apps
16211 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19447067FUROSEMIDE FORMULATIONS2026-01-13Pending00n/a
19384267CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE AND METHODS OF ADMINI…2025-11-10Pending00n/a
19271284PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE2025-07-16Pending314.8 mo
15569846Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15766454Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15491083Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15892494Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15629860Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15833214Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15196590Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 22 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in